Back to top

Recursion: "Hold" Rating Based On Initial REC-4881 FAP Treatment Data

Recursion: "Hold" Rating Based On Initial REC-4881 FAP Treatment Data

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Bayer Aktiengesellschaft (BAYRY)

Merck KGaA (MKKGY)

Roche Holding AG (RHHBY)

Recursion Pharmaceuticals, Inc. (RXRX)

Sanofi (SNY)